{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:35:59Z","timestamp":1753356959691},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.ygyno.2008.10.015","type":"journal-article","created":{"date-parts":[[2008,12,6]],"date-time":"2008-12-06T10:15:43Z","timestamp":1228558543000},"page":"394-399","source":"Crossref","is-referenced-by-count":18,"title":["Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed M\u00fcllerian tumors"],"prefix":"10.1016","volume":"112","author":[{"given":"Ursula A.","family":"Matulonis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen J.","family":"Krag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn N.","family":"Krasner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil S.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard T.","family":"Penson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2008.10.015_bib1","first-page":"524","article-title":"Ovarian cancer: survival and treatment differences by age","volume":"71","author":"Gloeckler","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.10.015_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/gyno.1998.5337","article-title":"Management of ovarian cancer patients older than 80\u00a0years of age","volume":"73","author":"Cloven","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.10.015_bib3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/cncr.2820710220","article-title":"Analysis of patient age as an independent prognostic factor for survival in a Phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and stage IV ovarian cancer","volume":"71","author":"Alberts","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.10.015_bib4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygyno.2005.06.005","article-title":"Surgical care of elderly women with ovarian cancer: a population-based study","volume":"99","author":"Diaz-Montes","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.10.015_bib5","first-page":"379","article-title":"Surgical treatment of the elderly patient with gynecologic cancer","volume":"170","author":"Kirschner","year":"1990","journal-title":"Surg. Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2008.10.015_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/cncr.2820710205","article-title":"Ovarian cancer: age contrasts in incidence, histology, disease stage at diagnosis, and mortality","volume":"71","author":"Yancik","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.10.015_bib7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/cncr.2820710218","article-title":"Age as a prognostic factor in ovarian carcinoma","volume":"71","author":"Thigpen","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.10.015_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0029-7844(03)00399-5","article-title":"Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?","volume":"102","author":"Chan","year":"2003","journal-title":"Obstetr. Gynecol."},{"key":"10.1016\/j.ygyno.2008.10.015_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ygyno.2008.03.008","article-title":"Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?","volume":"110","author":"Moore","year":"2008","journal-title":"Gn. Onc."},{"key":"10.1016\/j.ygyno.2008.10.015_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ygyno.2005.04.037","article-title":"Treatment patterns by decade of life in elderly women (\u226570\u00a0years of age) with ovarian cancer","volume":"98","author":"Uyar","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.10.015_bib11","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/sj.bjc.6604298","article-title":"Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival","volume":"98","author":"Wright","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2008.10.015_bib12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ygyno.2004.04.022","article-title":"Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer","volume":"94","author":"Hershman","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.10.015_bib13","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJM199912303412706","article-title":"Underrepresentation of patients 65\u00a0years of age or older in cancer-treatment trials","volume":"341","author":"Hutchins","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2008.10.015_bib14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ygyno.2004.05.033","article-title":"An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study","volume":"94","author":"Moore","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.10.015_bib15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/jnci\/88.15.1031","article-title":"Determinants of survival in older cancer patients","volume":"88","author":"Goodwin","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2008.10.015_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/gyno.1999.5591","article-title":"Gynecologic oncology surgery in the elderly: a retrospective analysis of 213 patients","volume":"75","author":"Susini","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.10.015_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ygyno.2007.04.012","article-title":"Response and outcomes in elderly patients with stages IIIC\u2013IV ovarian cancer receiving platinum-taxane chemotherapy","volume":"106","author":"Eisenhauer","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.10.015_bib18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment for Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2008.10.015_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0959-8049(00)00369-5","article-title":"Development of a European Organization for Research and Treatment of Cancer Questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report","volume":"37","author":"Cull","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2008.10.015_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chron. Disease."},{"key":"10.1016\/j.ygyno.2008.10.015_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1010-7940(02)00721-2","article-title":"Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer","volume":"23","author":"Birim","year":"2003","journal-title":"Eur. J. Cardiothor. Surg."},{"key":"10.1016\/j.ygyno.2008.10.015_bib22","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1046\/j.1532-5415.2001.49281.x","article-title":"The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community","volume":"49","author":"Saliba","year":"2001","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.ygyno.2008.10.015_bib23","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/jnci\/djh323","article-title":"Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma","volume":"96","author":"Vasey","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2008.10.015_bib24","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/cncr.23269","article-title":"Is there an optimal comorbidity index for prostate cancer?","volume":"112","author":"Alibhai","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.10.015_bib25","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbmt.2008.05.002","article-title":"Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin Lymphoma","volume":"14","author":"Wildes","year":"2008","journal-title":"Biol. Blood Marrow Transplant"},{"key":"10.1016\/j.ygyno.2008.10.015_bib26","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/cncr.23360","article-title":"Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advance non-small cell lung cancer (NSCLC) who are 70\u00a0years of age or older","volume":"112","author":"Simon","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.10.015_bib27","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ygyno.2006.06.019","article-title":"Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer","volume":"103","author":"Alps","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.10.015_bib28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0959-8049(02)00611-1","article-title":"Altered clearance of unbound paclitaxel in elderly patients with metastatic breast cancer","volume":"39","author":"Smorenburg","year":"2003","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2008.10.015_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2008.01.001","article-title":"Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients","volume":"109","author":"Nickles Fader","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.10.015_bib30","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/jnci\/88.15.1031","article-title":"Determinants of survival in older cancer patients","volume":"88","author":"Goodwin","year":"1996","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808008846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808008846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T01:32:25Z","timestamp":1557970345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808008846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0090825808008846"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.10.015","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}